Cours Titan Pharmaceuticals, Inc. OTC Bulletin Board
Actions
TTNP
US8883141017
Produits pharmaceutiques
CA 2022 | 557 k 498 k | CA 2023 | 184 k 164 k | Capitalisation | 6,21 M 5,55 M |
---|---|---|---|---|---|
Résultat net 2022 | -10 M -8,93 M | Résultat net 2023 | -5 M -4,47 M | VE / CA 2022 | 15,6 x |
Trésorerie nette 2022 | 2,75 M 2,46 M | Trésorerie nette 2023 | 6,2 M 5,53 M | VE / CA 2023 | 0,11 x |
PER 2022 |
-1,03
x | PER 2023 |
-1,11
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 54,53% |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 15/08/22 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 12/10/23 |
Brynner Chiam
BRD | Director/Board Member | - | 12/10/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+42,69% | 750 Md | |
+34,11% | 606 Md | |
-6,87% | 356 Md | |
+18,74% | 326 Md | |
+6,76% | 286 Md | |
+18,08% | 246 Md | |
-3,44% | 213 Md | |
+11,35% | 213 Md | |
+2,64% | 167 Md |